HOME ABOUT CONTACT PREVIOUS ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Intelligent Sensor Informs You to Change a Diaper via SMS       » University of Manchester & A*STAR ongoing partnership- Joint PhD programme       » Philippines Healthcare & New Digital Platform, MyDoc.       » Tapping on ASEAN'S Healthcare Opportunities through Singapore       » ASEAN: The New Playing Field for Global Medical Device Companies       » The Burden of Great Potential: the ASEAN Economic Community & Biopharmaceuticals       » When there is no Queen in the house, Asian Hive Bees Avoid Risky Foraging for Reproduction       » XELJANZTM (Tofacitinib Citrate), A new class of treatment for Rheumatoid Arthritis Approved in Singapore      
BIOBOARD - AUSTRALIA
Well-known antibiotic amoxycillin found to be ineffective cough treatment
A antibiotic commonly prescribed for infections including coughs and bronchitis is ineffective at relieving symptoms, and may actually be harmful if overused, according to a new European study.

The study of 2,061 adults, published in The Lancet Infectious Diseases, found patients prescribed amoxycillin did not recover more quickly or have significantly fewer symptoms than those who received no medication.

“Using amoxycillin to treat respiratory infections in patients not suspected of having pneumonia is not likely to help and could be harmful,” said Professor Paul Little from the University of Southampton in the UK who led the research.

He added that overuse of antibiotics could also lead to side effects such diarrhoea, rash, and vomiting, in addition to the development of resistance.

The study shows that unless a patient has pneumonia, the risk of side-effects outweighs the small benefit of treatment with the antibiotic, said Dr. Trent Yarwood, infectious diseases physician at Queensland Health.

“Thirty patients would need to be treated to prevent one having a worsening of their symptoms, but only 21 would need to be treated to result in an antibiotic-related side-effect (rash, nausea or diarrhoea),” Dr. Yarwood said.

However Dr. Michael Tam, GP and lecturer in primary care at the University of New South Wales, said the study doesn’t mean that antibiotics should never be used.

“For the most part, these findings confirm what we think to be best practice for lower respiratory tract infections that are not suspected to be pneumonia,” Dr. Tam said.

“For instance, the Australia based “eTG Complete” guidelines already recommend against the use of antibiotics for acute bronchitis.”

Dr. Tam said, as always, an individual seeking care should have a discussion with their GP on what would be the most appropriate treatment for them, at the time, in their specific situation.

“Our results show that most people get better on their own. But, given that a small number of patients will benefit from antibiotics the challenge remains to identify these individuals,” Professor Little said.

“Little and colleagues have generated convincing data that should encourage physicians in primary care to refrain from antibiotic treatment in low-risk patients in whom pneumonia is not suspected,” said Dr. Philipp Schuetz from the Kantonsspital Aarau in Switzerland.

“Whether this one size- fits-all approach can be further improved remains to be seen. Guidance from measurements of specific blood biomarkers of bacterial infection might help to identify the few individuals who will benefit from antibiotics despite the apparent absence of pneumonia and avoid the toxic effects and costs of those drugs and the development of resistance in other patients,” Dr. Schuetz said.

Charis Palmer
News Editor
Source: The Conversation

Click here for the complete issue.

EDITORS' CHOICE  

Credits to: American Chemical Society
COLUMNS  

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy